A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Phase of Trial: Phase II
Latest Information Update: 24 Apr 2015
At a glance
- Drugs Casopitant (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 07 Dec 2007 Status changed from in progress to completed.
- 27 Jan 2007 Status change
- 24 Oct 2006 New trial record.